1 study found for:    8827967 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Targeted Laser With Lucentis 0.5mg Verses L Lucentis 0.5mg Monotherapy for Ischemic Central Vein, Hemi Retinal Vein Occlusion and Branch Retinal Vein Occlusion
Condition: Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, Branch Retinal Vein Occlusion
Interventions: Drug: 0.5mg Ranibizumab;   Procedure: Targeted Pan Retinal Photocoagulation

Indicates status has not been verified in more than two years